Aortic & peripheral vascular disease

Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy

Eur Heart JPublished Mechanistic study

Authors' conclusion

Together, these findings provide critical insights into the functional differences and origin of macrophage subpopulations in human atherosclerosis and show their clinical significance and risk prediction value in relation to future cardiovascular events.

Study context

Population
Patients undergoing carotid endarterectomy (AtheroExpress cohort; validation in the Carotid Plaque Imaging Project)46 scRNA-seq
Outcome
MACE
Follow-up
3-year follow-up
Methodological detailssingle-cell RNA sequencing, bulk transcriptome deconvolution, external validation cohort
  • Single-cell RNA sequencing
  • Bulk transcriptome deconvolution
  • External validation cohort

Main finding

As reported in the abstract

  • Four major plaque macrophage archetypes identified: inflammatory macrophages, lipid-associated macrophages (LAMs), tissue-resident-like LAMs, inflammatory LAMs
  • Macrophages the only cell population significantly associated with both symptoms at surgery and increased MACE risk during 3-year follow-up
  • LAM and inflammatory LAM foam cell markers (e.g. PLIN2, TREM1) associated with increased MACE risk after 3-year follow-up
  • Associations validated in the Carotid Plaque Imaging Project cohort

Further findings

Macrophage origin

Derived from both classical and non-classical monocytes; monocytes can differentiate into inflammatory LAMs via inflammatory- or resident-like LAM and LAM stages

Original publication

Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy. Eur Heart J. Published 27 February 2026. doi:10.1093/eurheartj/ehag117

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.